Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2013
11/28/2013US20130316354 Mammalian cytokine; related reagents
11/28/2013US20130316350 Nucleic acid molecules containing recombination sites and methods of using the same
11/27/2013EP2666859A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
11/27/2013EP2666858A1 Modified iRNA agents
11/27/2013EP2666778A1 Nanoparticle, nanoparticle complex and method of preparing a nanoparticle
11/27/2013EP2666474A1 Peptides and related molecules that modulate nerve growth factor activity
11/27/2013EP2666473A1 Peptides and related molecules that modulate nerve growth factor activity
11/27/2013EP2665832A1 Methods and compositions for modified ethanol inducible promoter systems
11/27/2013EP2665740A1 Polymerase preference index
11/27/2013EP2665739A1 Methods and compositions related to synergistic responses to oncogenic mutations
11/27/2013CN103415302A Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
11/27/2013CN103408625A DNA purification method
11/26/2013US8592663 Tobacco nicotine demethylase genomic clone and uses thereof
11/26/2013US8592662 Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
11/26/2013US8592651 Antimicrobial peptides and uses thereof
11/26/2013US8592649 Functional expression of shuffled yeast nitrate transporter (YNT1) in maize to improve nitrate uptake under low nitrate environment
11/26/2013US8592647 Manipulation of ammonium transporters (AMTs) to improve NUE in higher plants
11/26/2013US8592646 Promoter, promoter control elements, and combinations, and uses thereof
11/26/2013US8592572 Liposome containing shRNA molecule targeting a thymidylate synthase and use thereof
11/26/2013US8592571 RNAi modulation of APOB and uses thereof
11/26/2013US8592570 Compositions and methods for inhibiting expression of an RNA from West Nile virus
11/26/2013US8592569 Small RNA-dependent translational regulatory system in cell or artificial cell model
11/26/2013US8592568 Nucleic acid probes and methods for detecting plasmodium parasites
11/26/2013US8592567 Vaccines and immunotherapeutics using codon-optimized IL-15 and methods for using the same
11/26/2013US8592562 Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
11/26/2013US8592557 Multimeric TNF receptor fusion proteins and nucleic acids encoding same
11/26/2013US8592542 Porous resin beads and method of producing nucleic acid using the same
11/26/2013US8592390 Immunostimulatory method
11/26/2013US8592389 MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
11/26/2013US8592388 Targeting MicroRNAs for metabolic disorders
11/26/2013US8592386 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
11/26/2013US8592384 Micro-RNA's that regulate muscle cells
11/26/2013US8592202 Biosensors for detecting macromolecules and other analytes
11/26/2013US8592200 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
11/26/2013US8592197 Functional influenza virus-like particles (VLPs)
11/26/2013US8592196 Modified influenza virus
11/26/2013US8592195 Fungal endoglucanases, their production and use
11/26/2013US8592194 Glucoamylase variants with altered properties
11/26/2013US8592193 High activity mutants of butyrylcholinesterase for cocaine hydrolysis
11/26/2013US8592184 Nucleic acid amplification in the presence of modified randomers
11/26/2013US8592182 High throughput nucleic acid sequencing by spacing
11/26/2013US8592181 Brazzein variant having higher sweetness and method for preparing multi-variant
11/26/2013US8592178 Process for the preparation of testosterone
11/26/2013US8592159 Method for detecting presumed IgA nephropathy and method for screening IgA nephropathy patients
11/26/2013US8592158 Detecting multinucleotide repeats
11/26/2013US8592148 Field-switch sequencing
11/26/2013US8591916 Flavivirus vaccine vector against influenza virus
11/26/2013US8591910 Chemically programmable immunity
11/26/2013US8591909 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
11/26/2013CA2541438C The modulation of hyaluronan synthesis and degradation in the treatment of disease
11/26/2013CA2482744C Hiv envelope-cd4 complexes and hybrids
11/26/2013CA2450710C Methods for the simultaneous detection of hcv antigens and hcv antibodies
11/26/2013CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013CA2417986C Single-labeled oligonucleotide probes
11/25/2013CA2815869A1 Method of determining the genotype relating to hereditary nasal parakeratosis (hnpk) and nucleic acids usable in said method
11/21/2013WO2013173638A1 Compositions and methods for modulating smn gene family expression
11/21/2013WO2013173637A1 Compositions and methods for modulating gene expression
11/21/2013WO2013173635A1 Compositions and methods for modulating gene expression
11/21/2013WO2013173608A1 Compositions and methods for modulating mecp2 expression
11/21/2013WO2013173605A1 Compositions and methods for modulating pten expression
11/21/2013WO2013173599A1 Compositions and methods for modulating hemoglobin gene family expression
11/21/2013WO2013173598A1 Compositions and methods for modulating atp2a2 expression
11/21/2013WO2013173475A2 Primers for analyzing methylated sequences and methods of use thereof
11/21/2013WO2013170735A1 Method for treating and/or preventing lung injury
11/21/2013WO2005042743A8 Humanization of antibodies
11/21/2013US20130312126 Methods and Compositions for RNAi Mediated Inhibition of Gene Expression in Mammals
11/21/2013US20130309752 Polypeptides Having Colanic Acid-Degrading Activity
11/21/2013US20130309173 Methods and compositions for maintenance of a functional wound
11/21/2013US20130306000 Aflaxtoxin Resistant Poultry
11/20/2013EP2664675A1 Primer group for detecting cpg island methylation of p16 gene using methylation-specific fluorescence technique
11/20/2013EP2664672A1 Modified iRNA agents
11/20/2013EP2663672A1 Prognostic signature for oral squamous cell carcinoma
11/20/2013EP2663642A2 Treponema pallidum triplet antigen
11/20/2013EP2292792B1 Compositions, methods and kits for determining the presence of Trichomonas Vaginalis in a test sample
11/20/2013EP2075334B1 EG-VEGF nucleic acids and polypeptides and methods of use
11/20/2013EP1841794B1 Adam-9 modulators
11/20/2013CN1832956B Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/20/2013CN103403543A Colon cancer gene expression signatures and methods of use
11/20/2013CN103403161A Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
11/20/2013CN103403016A Spatially modified gene expression in plants
11/20/2013CN103403015A Method for immobilising nucleic ligands
11/20/2013CN103397019A Use of interfering RNA in production of transgenic animals
11/20/2013CN101999001B Disease markers and uses thereof
11/20/2013CN101528921B Translocation and mutant ros kinase in human non-small cell lung carcinoma
11/20/2013CN101429262B Porous resin particle having hydroxy group or primary amino group and production method thereof
11/19/2013US8586830 Ioslated TT1 polynucleotide, encoded proteins and vectors for increasing tolerance of plants and microbes to abiotic stresses and the use thereof
11/19/2013US8586728 Oligonucleotides containing high concentrations of guanine monomers
11/19/2013US8586727 Synthetic mimics of miR-34
11/19/2013US8586726 Tissue-specific MicroRNAs and compositions and uses thereof
11/19/2013US8586725 MicroRNAome
11/19/2013US8586724 Oligonucleotides for amplifying Chlamydophila pneumoniae nucleic acid
11/19/2013US8586723 Genomic morse code
11/19/2013US8586722 Methods of using tubers having genetically modified potato plant cells
11/19/2013US8586721 Antibodies specific for DKK-1 and their uses
11/19/2013US8586720 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
11/19/2013US8586559 Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
11/19/2013US8586557 Therapy of p53 mutant colon adenocarcinoma, breast cancer and lung cancer
11/19/2013US8586555 Immunomodulatory compositions, formulations, and methods for use thereof
11/19/2013US8586531 Erythropoietin immunoglobulin fusion proteins
11/19/2013US8586350 Mechanism of separating and purifying DNA and the like
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 899